• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例在严重低血糖发作后诊断为肢端肥大症合并进展性糖尿病视网膜病变和肌肉减少症的病例。

A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia.

作者信息

Kubo Haremaru, Sugimoto Kazuhiro, Wada Ryota, Sekikawa Naohiro, Inoue Minoru

机构信息

Diabetes Center, Ohta Nishinouchi Hospital, Koriyama, JPN.

Diabetes, Endocrinology, and Metabolism, Kitasato University School of Medicine, Sagamihara, JPN.

出版信息

Cureus. 2024 Apr 17;16(4):e58461. doi: 10.7759/cureus.58461. eCollection 2024 Apr.

DOI:10.7759/cureus.58461
PMID:38765413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11100447/
Abstract

Acromegaly is a rare disorder characterized by excessive production of growth hormone (GH) from a pituitary tumor, typically leading to elevated glucose levels due to increased insulin resistance; hypoglycemia is rare. However, the long-term effect of excess GH on the peripheral organs is still unclear. Here we present a 69-year-old man evaluated for the cause of a hypoglycemic episode. He was underweight (body mass index: 17.3 kg/m) with sarcopenia, which potentially contributed to his hypoglycemia. Notably, he exhibited progressed proliferative diabetic retinopathy compared to other microvascular complications, leading to further endocrinological investigation. As a result, he was diagnosed with acromegaly showing elevated GH and insulin-like growth factor-1 (IGF-1) with a pituitary tumor. Opting against transsphenoidal surgery (TSS), the patient was treated with a somatostatin analog (SSA), achieving normalized IGF-1 levels with a monthly 120 mg lanreotide injection. In this case, acromegaly could lead to sarcopenia from GH-derived gluconeogenesis in the peripheral organs such as the reduction of muscle leading to reduced glucose reserves. Acromegaly in the elderly may present atypicality. Clinicians should be vigilant for unique manifestations such as advanced diabetic retinopathy, even in elderly patients with hypoglycemia.

摘要

肢端肥大症是一种罕见的疾病,其特征是垂体肿瘤过度分泌生长激素(GH),通常由于胰岛素抵抗增加导致血糖水平升高;低血糖很少见。然而,过量GH对周围器官的长期影响仍不清楚。在此,我们报告一名69岁男性,因低血糖发作的病因接受评估。他体重过轻(体重指数:17.3kg/m)且有肌肉减少症,这可能是导致他低血糖的原因。值得注意的是,与其他微血管并发症相比,他表现出进展性增殖性糖尿病视网膜病变,这促使进一步进行内分泌学检查。结果,他被诊断为肢端肥大症,伴有垂体肿瘤,生长激素和胰岛素样生长因子-1(IGF-1)水平升高。由于患者选择不接受经蝶窦手术(TSS),因此接受了生长抑素类似物(SSA)治疗,通过每月注射120mg兰瑞肽使IGF-1水平恢复正常。在这种情况下,肢端肥大症可能会因外周器官(如肌肉减少导致葡萄糖储备减少)中GH衍生的糖异生作用而导致肌肉减少症。老年肢端肥大症可能表现出非典型性。临床医生即使在患有低血糖的老年患者中,也应警惕诸如晚期糖尿病视网膜病变等独特表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/c14607bde39e/cureus-0016-00000058461-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/036fd8ad558a/cureus-0016-00000058461-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/7ea994d84214/cureus-0016-00000058461-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/9fb3ee268c9d/cureus-0016-00000058461-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/6a44c7d0b754/cureus-0016-00000058461-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/c14607bde39e/cureus-0016-00000058461-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/036fd8ad558a/cureus-0016-00000058461-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/7ea994d84214/cureus-0016-00000058461-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/9fb3ee268c9d/cureus-0016-00000058461-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/6a44c7d0b754/cureus-0016-00000058461-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/11100447/c14607bde39e/cureus-0016-00000058461-i05.jpg

相似文献

1
A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia.一例在严重低血糖发作后诊断为肢端肥大症合并进展性糖尿病视网膜病变和肌肉减少症的病例。
Cureus. 2024 Apr 17;16(4):e58461. doi: 10.7759/cureus.58461. eCollection 2024 Apr.
2
Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.内镜经蝶窦手术治疗肢端肥大症患者中肿瘤特征及术前术后激素水平对激素缓解的影响。
Neurosurg Focus. 2020 Jun;48(6):E10. doi: 10.3171/2020.3.FOCUS2080.
3
A rare challenging case of co-existent craniopharyngioma, acromegaly and squamous cell lung cancer.一例罕见的并存颅咽管瘤、肢端肥大症和鳞状细胞肺癌的疑难病例。
Endocrinol Diabetes Metab Case Rep. 2018 Mar 28;2018. doi: 10.1530/EDM-18-0018. eCollection 2018.
4
Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.肢端肥大症患者经垂体手术后,体重指数和胰岛素样生长因子 1 是导致生长激素和胰岛素样生长因子 1 水平不一致的危险因素。
J Formos Med Assoc. 2018 Jan;117(1):34-41. doi: 10.1016/j.jfma.2017.02.014. Epub 2017 Mar 21.
5
Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.肢端肥大症的医学治疗:合并症及其通过生长抑素类似物的可逆性
Neuroendocrinology. 2006;83(3-4):249-57. doi: 10.1159/000095535. Epub 2006 Oct 13.
6
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group.长效兰瑞肽治疗活动性肢端肥大症的有效性和耐受性:一项意大利多中心研究的六个月报告。意大利多中心长效兰瑞肽研究组
J Clin Endocrinol Metab. 1996 Jun;81(6):2089-97. doi: 10.1210/jcem.81.6.8964833.
7
How effective are current therapies for acromegaly?目前治疗肢端肥大症的疗法效果如何?
Growth Horm IGF Res. 2003 Aug;13 Suppl A:S144-51. doi: 10.1016/s1096-6374(03)00072-8.
8
Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.肢端肥大症伴胰岛素样生长因子-1(IGF-1)水平正常,可能是由于糖尿病控制不佳所致。
Tohoku J Exp Med. 2008 Dec;216(4):325-9. doi: 10.1620/tjem.216.325.
9
[Lowered ghrelin levels in acromegaly—normalization after treatment].[肢端肥大症患者胃饥饿素水平降低——治疗后恢复正常]
Endokrynol Pol. 2005 Nov-Dec;56(6):862-70.
10
Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?肢端肥大症生化缓解的临床指标:疾病控制不完全是否总是意味着治疗失败?
Clin Endocrinol (Oxf). 2005 Apr;62(4):410-7. doi: 10.1111/j.1365-2265.2005.02233.x.

本文引用的文献

1
Skeletal Muscle Evaluation in Patients With Acromegaly.肢端肥大症患者的骨骼肌评估
J Endocr Soc. 2024 Feb 18;8(4):bvae032. doi: 10.1210/jendso/bvae032. eCollection 2024 Feb 19.
2
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.6. 血糖目标与低血糖:2024年糖尿病诊疗标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
3
Secondary diabetes mellitus in acromegaly.肢端肥大症中的继发性糖尿病。
Endocrine. 2023 Jul;81(1):1-15. doi: 10.1007/s12020-023-03339-1. Epub 2023 Mar 8.
4
Insulin Autoimmune Syndrome: A Systematic Review.胰岛素自身免疫综合征:一项系统评价
Int J Endocrinol. 2023 Feb 15;2023:1225676. doi: 10.1155/2023/1225676. eCollection 2023.
5
HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease.短暂性低血糖反应导致 HIF-1α 堆积可能使糖尿病眼病恶化。
Cell Rep. 2023 Jan 31;42(1):111976. doi: 10.1016/j.celrep.2022.111976. Epub 2023 Jan 10.
6
Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus.肌肉减少症与 2 型糖尿病的慢性并发症。
Rev Diabet Stud. 2022 Sep 28;18(3):157-165. doi: 10.1900/RDS.2022.18.157.
7
Advanced proliferative diabetic retinopathy and macular edema in acromegaly: a case report and literature review.肢端肥大症患者的晚期增殖性糖尿病视网膜病变和黄斑水肿:一例报告及文献综述
Diabetol Int. 2022 Jan 25;13(3):575-579. doi: 10.1007/s13340-022-00571-4. eCollection 2022 Jul.
8
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study.肢端肥大症的多维老年评估:一项比较性横断面研究。
BMC Geriatr. 2021 Oct 26;21(1):598. doi: 10.1186/s12877-021-02549-4.
9
Sarcopenia, frailty and type 2 diabetes mellitus (Review).肌肉减少症、衰弱与 2 型糖尿病(综述)。
Mol Med Rep. 2021 Dec;24(6). doi: 10.3892/mmr.2021.12494. Epub 2021 Oct 15.
10
Growth hormone promotes hepatic gluconeogenesis by enhancing BTG2-YY1 signaling pathway.生长激素通过增强 BTG2-YY1 信号通路促进肝糖异生。
Sci Rep. 2021 Sep 23;11(1):18999. doi: 10.1038/s41598-021-98537-0.